Attention cannabis businesses, have you considered how new research findings about the benefits or potential downsides of cannabis consumption will impact your business strategy, investment opportunities, and product development?
As the cannabis industry continues to grow and evolve, it’s crucial for businesses to stay informed and up-to-date with the latest research to succeed. This week we are joined by industry expert and CEO of EndoCanna Health, Len May, to discuss the science of cannabis and how businesses can stay agile with product development and marketing strategies that maintain regulatory compliance as new research findings are released.
Len built his business around personalized cannabis therapeutics based on DNA sequencing for individuals to improve product efficacy and make cannabis experiences more enjoyable. Personalized medicine is important for drug efficacy, and understanding genetic predispositions can help to avoid negative experiences when using cannabis products. Knowing how different cannabinoids affect the body can help consumers avoid triggering negative epigenetic expressions, such as paranoia, and help companies to develop products better suited to their objective or claim.
During the webinar, you will learn about:
- The physiology of cannabis: how different varietals affect the body, dosage, and outcomes
- How businesses can use research developments to create products tailored to consumer preferences
- How research can influence investment decisions in the cannabis industry
Join us and dig into Len’s journey with DNA sequencing and stay informed about the latest cannabis research for businesses to succeed in this rapidly evolving industry. Save your spot!